Source: Journal of Cellular Biochemistry. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS, CARCINOMA, CÓRTEX ADRENAL, BIOMARCADORES, REGULAÇÃO NEOPLÁSICA DA EXPRESSÃO GÊNICA, ESTEROIDES
ABNT
VERONEZ, Luciana Chain et al. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, v. 122, n. 12, p. 1925-1935, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcb.30153. Acesso em: 30 ago. 2024.APA
Veronez, L. C., Chagas, P. F. das, Correa, C. A. P., Baroni, M., Silva, K. R. da, Nagano, L. F. P., et al. (2021). MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways. Journal of Cellular Biochemistry, 122( 12), 1925-1935. doi:10.1002/jcb.30153NLM
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1002/jcb.30153Vancouver
Veronez LC, Chagas PF das, Correa CAP, Baroni M, Silva KR da, Nagano LFP, Borges KS, Queiroz RG de P, Tone LG, Scrideli CA. MSI2 expression in adrenocortical carcinoma: Association with unfavorable prognosis and correlation with steroid and immune‐related pathways [Internet]. Journal of Cellular Biochemistry. 2021 ; 122( 12): 1925-1935.[citado 2024 ago. 30 ] Available from: https://doi.org/10.1002/jcb.30153